Medical News

RSS

FDA grants marketing approval for Wright Medical Group's CONSERVE Plus Total Hip Resurfacing System

Wright Medical Group, Inc., a global orthopaedic medical device company, announced today that the United States Food and Drug Administration (FDA) has given approval to the Company to market its original CONSERVE® Plus Total Hip Resurfacing System. Now available in the United States, this innovative total surface arthroplasty system provides surgeons and their patients a bone-conserving alternative to traditional total hip replacement.

9 Nov 2009

Prescient Medical to showcase its vProtect Luminal Shield and the vPredict Optical Catheter System

Two products from Prescient Medical -- the vProtect(TM) Luminal Shield and the vPredict(TM) Optical Catheter System -- will be featured at the 3rd Annual Canaccord Adams Cardiovascular Conference. The conference will take place on Tuesday, November 10th in San Francisco, California, and will bring together a select group of med-tech and biotech companies focused on the most important markets in cardiovascular medicine.

9 Nov 2009

TivaMed changes its name to Viveve

Women's sexual health company, TivaMed, today announced it has changed its name to Viveve as it prepares for a 2010 launch of its Viveve system to OB/GYNs in select U.S. markets.

9 Nov 2009

Shire's INTUNIV for treating ADHD now available in the U.S.

Shire plc, the global specialty biopharmaceutical company, today announced the availability of INTUNIV(TM) (guanfacine) Extended Release Tablets in pharmacies across the United States for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17.

9 Nov 2009

EMSC to acquire Pinnacle Anesthesia Consultants and Pinnacle Consultants Mid Atlantic

Emergency Medical Services Corporation today announced that it has significantly expanded its anesthesiology services via definitive agreements to acquire Pinnacle Consultants Mid Atlantic and the management services company of Pinnacle Anesthesia Consultants, P.A. (the “MSO”).

9 Nov 2009

Positive study data from Zosano Pharma's ZP-PTH transdermal patch for treating osteoporosis

Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism of results from a positive phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis.

9 Nov 2009

Access MediQuip relocates its corporate headquarters to Lake Mary, Florida

Access MediQuip, LLC, the nation's first and largest provider of outsourced implantable medical device management solutions to the healthcare industry, announced today that it is relocating its corporate headquarters to Lake Mary, Florida. The move, prompted by the firm's continued rapid growth, includes a major expansion of the Primera Blvd, Lake Mary office space that will open in January 2010 and relocation and expansion of the Houston facilities to the new, LEED® certified, One & Two Oak Park complex in the Westchase District.

9 Nov 2009

Assisted Living Concepts reports financial results for third-quarter 2009

Assisted Living Concepts, Inc. ("ALC") reported net income from continuing operations and net income of $4.2 million and $3.4 million, respectively, in the third quarter of 2009 compared to net income from continuing operations and net income of $3.1 million and $3.0 million, respectively in the third quarter of 2008.

9 Nov 2009

Clinipace acquires Worldwide Clinical Research, changes its name to Clinipace Worldwide

Clinipace, a global technology-driven clinical research organization (CRO), announced today that on October 26th, 2009 the company closed its acquisition of Worldwide Clinical Research, Inc. (WWCR), a Midwest-based CRO specializing in the management of clinical studies for biotechnology and pharmaceutical companies. With the acquisition, Clinipace has changed its name to Clinipace Worldwide.

9 Nov 2009

Fire & Emergency Medical Services Division launched by KCE

Kaplan Continuing Education (KCE) has launched a Fire & Emergency Medical Services (EMS) Division with the assistance of Florida Professional Firefighters Medical Director and former National Paramedic Institute president Dr. Steven Katz. Kaplan’s online continuing education courses offer EMT CEUs online for students recertifying their state certifications.

9 Nov 2009

With House hurdle cleared, Democrats reflect on health bill compromises

The Washington Post: "House Speaker Nancy Pelosi (D-Calif.) and her leadership team won a hard-fought victory on Obama's most critical domestic policy agenda item by neutralizing the most potentially toxic political issue well in advance of the final vote, siding with centrists on their preferred version of the public option. She then publicly dared the progressive wing, with its strong commitment to establishing national health insurance, to take down the entire package because one piece was not to their liking."

9 Nov 2009

Age rating to continue under health care bills

The Los Angeles Times reports that the health care proposals being considered by Congress would prohibit insurers from charging higher premiums based on preexisting conditions, "[b]ut the far reaching clampdown on insurers leaves one highly controversial element untouched: the issue of charging higher premiums to older policyholders than to younger, presumably healthier consumers who are less likely to file costly claims.

9 Nov 2009

HemaCare reports financial results for the third quarter of 2009

HemaCare Corporation announced today third quarter 2009 results, which include a 168% increase in income from operations compared to the same quarter of 2008. Income from operations was $158,000 versus $59,000 for the third quarter of 2008, and $659,000 on a year-to-date basis, compared to $422,000 in 2008.

9 Nov 2009

Smoking has a direct negative impact on postoperative outcomes

With the American Cancer Society's Great American Smokeout Challenge just a week away, the American Society of Anesthesiologists (ASA) is giving smokers yet another reason to quit. The scientific evidence is clear -- smoking has a direct negative impact on postoperative outcomes. Quitting smoking is one of the best things people can do to improve their chances of recovering from surgery without complications.

9 Nov 2009

Covisint and Carefx partner to market an integrated workflow solution for health information exchange

Addressing the burgeoning demand for health information exchange (HIE) to coordinate and better leverage patient information, two health IT industry leaders - Covisint, a subsidiary of Compuware Corporation, and Carefx - have partnered to market an integrated workflow solution that ties together the full spectrum of care, from physician offices to labs and pharmacies, to multiple information systems within hospitals.

9 Nov 2009

Chicago Prostate Cancer Center offers free prostate cancer guide

Prostate cancer is the second most common cancer in American men. One in six men will be diagnosed during his lifetime, according to the American Cancer Society.

9 Nov 2009

Emisphere Technologies' key product developments and financial results for the third quarter of 2009

Emisphere Technologies, Inc. today announced financial and operational results for the third quarter and nine months ended September 30, 2009.

9 Nov 2009

CytRx reports financial results for the three months and nine months ended September 30, 2009

CytRx Corporation, a biopharmaceutical company, today reported financial results for the three months and nine months ended September 30, 2009.

9 Nov 2009

Covidien contraindicates use of its Optimark gadoversetamide injection

Covidien, a leading global provider of healthcare products, today announced that it will voluntarily contraindicate the use of its Optimark™ gadoversetamide injection, a gadolinium-based contrast agent (GBCA), in magnetic resonance imaging (MRI) procedures involving patients with severe renal impairment.

9 Nov 2009

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon’s four marketed specialty pharmaceutical products through 2014.

9 Nov 2009

Medical News

FDA grants marketing approval for Wright Medical Group's CONSERVE Plus Total Hip Resurfacing System

Prescient Medical to showcase its vProtect Luminal Shield and the vPredict Optical Catheter System

TivaMed changes its name to Viveve

Shire's INTUNIV for treating ADHD now available in the U.S.

EMSC to acquire Pinnacle Anesthesia Consultants and Pinnacle Consultants Mid Atlantic

Positive study data from Zosano Pharma's ZP-PTH transdermal patch for treating osteoporosis

Access MediQuip relocates its corporate headquarters to Lake Mary, Florida

Assisted Living Concepts reports financial results for third-quarter 2009

Clinipace acquires Worldwide Clinical Research, changes its name to Clinipace Worldwide

Fire & Emergency Medical Services Division launched by KCE

With House hurdle cleared, Democrats reflect on health bill compromises

Age rating to continue under health care bills

HemaCare reports financial results for the third quarter of 2009

Smoking has a direct negative impact on postoperative outcomes

Covisint and Carefx partner to market an integrated workflow solution for health information exchange

Chicago Prostate Cancer Center offers free prostate cancer guide

Emisphere Technologies' key product developments and financial results for the third quarter of 2009

CytRx reports financial results for the three months and nine months ended September 30, 2009

Covidien contraindicates use of its Optimark gadoversetamide injection

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News